Notably, RACK1 is upregulated in cancers like colorectal adenocarcinoma, hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and melanoma, highlighting its significant role in cancer progression and development [20,23,40,41,42,43]. Here, RACK1 is linked to breast cancer.